Dier Mardi sold MDGL
December 2, 2025 · Form 4 insider transaction
Dier Mardi sold 717 shares of Madrigal Pharmaceuticals, Inc. at $574.00 per share, a transaction worth $411.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
717
Price
$574.00
Total value
$411.6K
InsiderDier Mardi
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 2, 2025
Filing dateDecember 3, 2025
Shares owned after12,812
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.59 to $574.44, inclusive.